1. Xu Y, Xu M, Tong J, Tang X, Chen J, Chen X, Zhang Z, Cao B, Moran MF, Wu D*, Mao X*.

Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma. Blood. 2021 Mar

18;137(11):1478-1490.

2. Xu Y#, Zhang Z#, Li J#, Tong J, Cao B, Taylor P, Tang X, Wu D, Moran M, Zeng Y*, Mao X*.

The ubiquitin conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis. J

Hematol Oncol, 2017 Jul 3;10(1):132.

3. Yujia Xu#, Tong Sun#, Kun Zeng, Min Xu, Jinhao Chen, Xiaofeng Xu, Zubin Zhang, Biyin

Cao, Xiaowen Tang, Depei Wu, Yan Kong, Yuanying Zeng*, Xinliang Mao*. Anti-bacterial and anti-viral

nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf. Cell Death Dis. 2020 Sep

30;11(9):818.

6. Xue-Han Chen#, Yujia Xu#, Xiao-Ge Wang#, Peng Lin, Bi-Yin Cao, Yuan-Ying Zeng, Qi Wang,

Zu-Bin Zhang*, Xin-Liang Mao*, Tie Zhang*. Mebendazole elicits potent antimyeloma activity by

inhibiting the USP5/c-Maf axis. Acta Pharmacol Sin. 2019 Dec;40(12):1568-1577.

7. Xu Y#, Zeng K#, Wang X, Zhang J, Cao B, Zhang Z, Qiao C, Xu X, Wang Q, Zeng Y, Mao X.

Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the

IGF1-R/AKT/mTOR signaling pathway. Biosci Trends. 2020 May 21;14(2):96-103.

8. Zhuan Xu#, Yu-Jia Xu#, Ya-Nan Hao#, Li-Jie Ren, Zu-Bin Zhang, Xin Xu, Bi-Yin Cao, Ke-Sheng

Dai, Li Zhu, Qi Fang*, Yan Kong*, Xin-Liang Mao*. A novel STAT3 inhibitor negatively modulates

platelet activation and aggregation. Acta Pharmacol Sin. 2017 May;38(5):651-659.

代表性成果：